aryx therapeutics inc (ARYX:OTC US)
Armen Tashjian Jr., M.D.
Former Member of Scientific Advisory Board, ARYx Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 9 board members in 1 different organizations across 4 different industries.|
See Board Relationships
Armen H. Tashjian, Jr., M.D., Ph.D., serves as a Consultant to several pharmaceutical and biotechnology companies, and bioventure funds. Dr. Tashjian serves as Professor of Biological Chemistry, Molecular Pharmacology, Toxicology, Emeritus, in the Department of Cancer Cell Biology at the HSPH. Dr. Tashjian is the Deputy Editor of the recently published in 2004 textbook entitled Principles of Pharmacology: The Pathophysiological Basis of Drug Therapy. He also served as ...
6300 Dumbarton CirclePhone: 510-585-2200
Fremont, California 94555
Board Members Memberships*
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|Peter S. Greenleaf||Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee|
Sucampo Pharmaceuticals, Inc.
|Eduardo Javier Sanchiz Yrazu||Chief Executive Officer, Chief Executive of Corporate Development & Finance, Executive Director, Member of Management Board and Member of Compliance Committee|
|--||Compensation as of Fiscal Year 2013.|